Mary Szela

Ms Szela is currently chief executive officer of TriSalus Life Sciences, an oncology company integrating standard-of-care treatments and our novel immunotherapy with disruptive delivery technology to trans-form the treatment paradigm for patients battling liver and pancreatic tumors. Ms Szela has an M.B.A. from the University of Illinois at Chicago, and a B.S. Nursing degree from the University of Illinois at Chicago.